Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingxing Ke

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Sensors (Basel, Switzerland)|May 9, 2018
Distributed Power Allocation for Wireless Sensor Network Localization: A Potential Game ApproachMingxing Ke, Ding Li, Shiwei Tian, et al.
Molecular Imaging and Biology|July 16, 2021
Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast CancersZhaoguo Han, Mingxing Ke, Xiang Liu, et al.
Biomaterials Science|April 3, 2020
Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancerLili Yang, Shanshan Liu, Jingjing Chu, et al.
Biomaterials Science|April 11, 2022
Correction: Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancerLili Yang, Shanshan Liu, Jingjing Chu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Sensors (Basel, Switzerland)|May 9, 2018
Distributed Power Allocation for Wireless Sensor Network Localization: A Potential Game ApproachMingxing Ke, Ding Li, Shiwei Tian, et al.
Molecular Imaging and Biology|July 16, 2021
Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast CancersZhaoguo Han, Mingxing Ke, Xiang Liu, et al.
Biomaterials Science|April 3, 2020
Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancerLili Yang, Shanshan Liu, Jingjing Chu, et al.
Biomaterials Science|April 11, 2022
Correction: Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancerLili Yang, Shanshan Liu, Jingjing Chu, et al.
Pageof 1